Cargando…

Retinal microvascular changes in diabetic patients with diabetic nephropathy

BACKGROUND: To explore the characteristics of retina microvascular changes in patients with diabetic nephropathy (DN) and its risk factors. METHODS: Retrospective, observational study. 145 patients with type 2 diabetic mellitus (DM) and DN were included in the study. Demographic and clinical paramet...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yujie, Yu, Liping, Sun, Chuan, Zhao, Haipeng, Zhang, Hongsong, Wang, Zhijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161482/
https://www.ncbi.nlm.nih.gov/pubmed/37147636
http://dx.doi.org/10.1186/s12902-022-01250-w
_version_ 1785037504091521024
author Yan, Yujie
Yu, Liping
Sun, Chuan
Zhao, Haipeng
Zhang, Hongsong
Wang, Zhijun
author_facet Yan, Yujie
Yu, Liping
Sun, Chuan
Zhao, Haipeng
Zhang, Hongsong
Wang, Zhijun
author_sort Yan, Yujie
collection PubMed
description BACKGROUND: To explore the characteristics of retina microvascular changes in patients with diabetic nephropathy (DN) and its risk factors. METHODS: Retrospective, observational study. 145 patients with type 2 diabetic mellitus (DM) and DN were included in the study. Demographic and clinical parameters were obtained from medical records. Presence of diabetic retinopathy (DR), hard exudates (HEs) and diabetic macular edema (DME) were evaluated according to the color fundus images, optical coherence tomography (OCT) and fluorescence angiography (FFA). RESULTS: DR accounted for 61.4% in type 2 DM patients with DN, of which proliferative diabetic retinopathy (PDR) accounted for 23.6% and sight threatening DR accounted for 35.7%. DR group had significantly higher levels of low-density lipoprotein cholesterol (LDL-C) (p = 0.004), HbA1c (P = 0.037), Urine albumin creatine ratio (ACR) (p < 0.001) and lower level of estimated glomerular filtration rate (eGFR) (P = 0.013). Logistic regression analysis showed DR was significantly associated with ACR stage (p = 0.011). Subjects with ACR stage3 had higher incidence of DR compared with subjects with ACR stage1 (OR = 24.15, 95%CI: 2.06–282.95). 138 eyes of 138 patients were analyzed for HEs and DME, of which 23.2% had HEs in posterior pole and 9.4% had DME. Visual acuity was worse in HEs group than in non-HEs group. There was significant difference in the LDL-C cholesterol level, total cholesterol (CHOL) level and ACR between HEs group and non-HEs group. CONCLUSIONS: A relatively higher prevalence of DR was found in type 2 DM patients with DN. ACR stage could be recognized as a risk factor for DR in DN patients. Patients with DN needs ophthalmic examination more timely and more frequently. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12902-022-01250-w.
format Online
Article
Text
id pubmed-10161482
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101614822023-05-06 Retinal microvascular changes in diabetic patients with diabetic nephropathy Yan, Yujie Yu, Liping Sun, Chuan Zhao, Haipeng Zhang, Hongsong Wang, Zhijun BMC Endocr Disord Research Article BACKGROUND: To explore the characteristics of retina microvascular changes in patients with diabetic nephropathy (DN) and its risk factors. METHODS: Retrospective, observational study. 145 patients with type 2 diabetic mellitus (DM) and DN were included in the study. Demographic and clinical parameters were obtained from medical records. Presence of diabetic retinopathy (DR), hard exudates (HEs) and diabetic macular edema (DME) were evaluated according to the color fundus images, optical coherence tomography (OCT) and fluorescence angiography (FFA). RESULTS: DR accounted for 61.4% in type 2 DM patients with DN, of which proliferative diabetic retinopathy (PDR) accounted for 23.6% and sight threatening DR accounted for 35.7%. DR group had significantly higher levels of low-density lipoprotein cholesterol (LDL-C) (p = 0.004), HbA1c (P = 0.037), Urine albumin creatine ratio (ACR) (p < 0.001) and lower level of estimated glomerular filtration rate (eGFR) (P = 0.013). Logistic regression analysis showed DR was significantly associated with ACR stage (p = 0.011). Subjects with ACR stage3 had higher incidence of DR compared with subjects with ACR stage1 (OR = 24.15, 95%CI: 2.06–282.95). 138 eyes of 138 patients were analyzed for HEs and DME, of which 23.2% had HEs in posterior pole and 9.4% had DME. Visual acuity was worse in HEs group than in non-HEs group. There was significant difference in the LDL-C cholesterol level, total cholesterol (CHOL) level and ACR between HEs group and non-HEs group. CONCLUSIONS: A relatively higher prevalence of DR was found in type 2 DM patients with DN. ACR stage could be recognized as a risk factor for DR in DN patients. Patients with DN needs ophthalmic examination more timely and more frequently. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12902-022-01250-w. BioMed Central 2023-05-05 /pmc/articles/PMC10161482/ /pubmed/37147636 http://dx.doi.org/10.1186/s12902-022-01250-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Yan, Yujie
Yu, Liping
Sun, Chuan
Zhao, Haipeng
Zhang, Hongsong
Wang, Zhijun
Retinal microvascular changes in diabetic patients with diabetic nephropathy
title Retinal microvascular changes in diabetic patients with diabetic nephropathy
title_full Retinal microvascular changes in diabetic patients with diabetic nephropathy
title_fullStr Retinal microvascular changes in diabetic patients with diabetic nephropathy
title_full_unstemmed Retinal microvascular changes in diabetic patients with diabetic nephropathy
title_short Retinal microvascular changes in diabetic patients with diabetic nephropathy
title_sort retinal microvascular changes in diabetic patients with diabetic nephropathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161482/
https://www.ncbi.nlm.nih.gov/pubmed/37147636
http://dx.doi.org/10.1186/s12902-022-01250-w
work_keys_str_mv AT yanyujie retinalmicrovascularchangesindiabeticpatientswithdiabeticnephropathy
AT yuliping retinalmicrovascularchangesindiabeticpatientswithdiabeticnephropathy
AT sunchuan retinalmicrovascularchangesindiabeticpatientswithdiabeticnephropathy
AT zhaohaipeng retinalmicrovascularchangesindiabeticpatientswithdiabeticnephropathy
AT zhanghongsong retinalmicrovascularchangesindiabeticpatientswithdiabeticnephropathy
AT wangzhijun retinalmicrovascularchangesindiabeticpatientswithdiabeticnephropathy